Description
+ Include: 23 videos + 1 pdf, size: 5.44 GB
+ Target Audience: physicians, and nurses who care for oncology patient
+ Sample video: contact me for sample video
+ Information:
Wednesday, January 24, 2024, 8:00 AM – 5:20 PM, Online, New York , NY
Immunotherapeutics has changed the landscape of treatment modalities available to the cancer patient in both solid tumor and hematologic malignancies. Since the breakthrough of ipilimumab, there have been fast-paced and ongoing advancements in the field of immunotherapy, revolutionizing clinical management at a rapid pace.
This one-day virtual symposium will review fundamental concepts and recent advances in immunotherapy designed to meet the learning needs of advanced practice providers (APPs) and other allied health professionals. Clinical application in solid tumor and hematologic malignancies will be discussed as well as toxicity management, including immune-related adverse events resulting from immune checkpoint inhibition.
Experts will discuss the fundamentals of immune checkpoint blockade and CAR T cell therapy, as well as advancements in TIL and BITE therapy, novel combination therapy, and algorithmic management of immune-related adverse events. Toxicity management will be communicated through case study applications and demonstration of common, rare, and severe immune-related adverse events.
The overall goal of this program is to improve cancer patient outcomes by advancing the science, development, and application of cancer immunology and immunotherapy through fundamental understanding and clinical application.
Attendees of this symposium will receive access to an online syllabus, which includes select video recordings of the lectures.
Target Audience
The target audience for this course includes nurse practitioners, physician assistants, certified registered nurse anesthetists, physicians, and nurses who care for oncology patient.
- Describe the principles surrounding the immunity cycle
- Explain fundamental principles of immunotherapeutic agents including immune checkpoint inhibition, CAR T cell, TIL, and BITE therapies.
- Discuss the symptoms of Cytokine release Syndrome, ICANS, prolonged cytopenias and clinical management
- Recognize and identify common, rare, and severe immune related adverse events attributed to immune checkpoint inhibition
- Discuss clinical application of immune modulated agents in the oncology population
+ Topics:
APPImmuno2024_Brochure.pdf
Arthralgias and Myalgias.mp4
Benefit of Adjuvant Combination Therapy vs. Surveillance in High Risk Hepatocellular Carcinoma Patients.mp4
Clinical Landscape of Immunotherapy in Soft Tissue Sarcoma- Fundamentals and Advances in Immunotherapy.mp4
Dermatologic irAEs.mp4
FDA Approved CAR T Products in the Treatment and Management of Leukemia.mp4
Fundamentals of Chimeric Antigen Receptor (CAR) T Cell Immunotherapy.mp4
Hepatotoxicty.mp4
Immunotherapy and CAR T Cell Therapy in Hematologic Malignancies Lymphoma.mp4
Immunotherapy Induced Diabletes Mellitus.mp4
Implementation of Cellular Therapy in the Solid Tumor Population- The Use of TIL Therapy in Melanoma.mp4
Mechanism of Action of Checkpoint Blockade With a Focus on PD1, PDL1, and CTLA-4.mp4
Neoadjuvant Combination Modalites in Resectable Non Small Cell Lung Cancer.mp4
Novel Checkpoint Inhibitors and Combination Therapy in the Clinical Setting.mp4
Novel Immune Modulated Agents in the Treatment of Glioblastoma.mp4
Overall Survival (OS) in Recurrent or Metastatic Cervical Cancer Using Combination Therapy.mp4
Overview of Adverse Events in the Cellular Therapy Patient- CRS, ICANS, and Prolonged Cytopenias.mp4
Panel Discussion- Clinical Application of Immune Checkpoint Inhibitors in Solid Tumor Malignancy.mp4
Panel Discussion- Clinical Application of Immune Therapy in Hematologic Malignancy.mp4
Panel Discussion- Clinical Updates in Solid Tumor and Novel Immune Modulation.mp4
Panel Discussion- Diagnosis and Clinical Management of Immune Related Adverse Events (irAE).mp4
Panel Discussion- Fundamentals of T Cell Therapy.mp4
Pneumonitis.mp4
T Cell Re-Directing Therapy in Multiple Myeloma.mp4
Reviews
There are no reviews yet.